Latest News and Information on Allergan

Published on Tuesday 7th of September 2010 03:52:35 AM

Kendall Law Group Investigates Allergan, Inc. for Shareholders
MarketWatch (press release)
Allergan agreed to plead guilty to one criminal misdemeanor charge, to pay $375 million to the government for misbranding Botox, and to pay $225 million to ...

and more »

Published on Tuesday 7th of September 2010 03:52:35 AM

Allergan Agrees to Pay $600 Million to Settle Botox Investigation
Daily Rosetta
Allergan Inc. (AGN), the maker of Botox, agreed on Wednesday to pay $600 million to settle charges that it illegally promoted and sold the drug through 2005 ...

Published on Tuesday 7th of September 2010 03:52:35 AM

Law Offices of Howard G. Smith Announces Investigation on Behalf of ...
MarketWatch (press release)
Allergan is a multi-specialty healthcare company, engaged in the discovery, development, and commercialization of specialty pharmaceutical, medical device ...

and more »

Published on Tuesday 7th of September 2010 03:52:35 AM

The Law Office of Robbins Umeda LLP Announces Investigation of Allergan, Inc.
MarketWatch (press release)
Allergan is a multi-specialty healthcare company that discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter ...

and more »

Published on Tuesday 7th of September 2010 03:52:35 AM

Inspire Pharma amends Allergan collaboration deal
BusinessWeek
Inspire Pharmaceuticals has stopped the development of a dry eye disease drug candidate and amended its collaboration agreement with Allergan Inc., ...
Inspire Announces Amendment to Ophthalmic Collaboration MarketWatch (press release)
Inspire shelves dry-eye drug, shifts focus with Allergan Triangle Business Journal
Allergan Rallies on News of License Agreement BloggingStocks (blog)
OSN SuperSite - Local Tech Wire (blog) - FierceBiotech
all 44 news articles »

Published on Tuesday 7th of September 2010 03:52:35 AM

Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line ...
MarketWatch (press release)
"LUMIGAN(R) 0.01% exemplifies Allergan's commitment to developing medications for glaucoma patients that maximize efficacy while minimizing drug exposure. ...
Allergan's elevated intraocular pressure treatment gets nod from FDA Drug Store News
Allergan says new version of Lumigan approved BusinessWeek

all 33 news articles »

Published on Tuesday 7th of September 2010 03:52:35 AM

Do not forget to check the lastest products and auctions related to Allergan as well as our free videos and podcasts.

Brazil: the largest country in South America declared its independence from Portugal (1822)